Income Statement

Currency: CNY

	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025
Revenue
Interest Expense	0	0	1	1	1	1	1	1	1	1	0
Revenue	221 N/A	245 +11%	260 +6%	312 +20%	329 +5%	182 -45%	291 +60%	384 +32%	413 +8%	428 +4%	439 +2%
Gross Profit
Cost of Revenue	(65)	(72)	(81)	(98)	(121)	(75)	(122)	(162)	(173)	(180)	(182)
Gross Profit	156 N/A	173 +11%	179 +4%	215 +20%	209 -3%	107 -49%	169 +58%	222 +31%	240 +8%	248 +4%	257 +3%
Operating Income
Operating Expenses	(164)	(179)	(187)	(235)	(229)	(120)	(175)	(208)	(209)	(206)	(210)
Selling, General & Administrative	(103)	(112)	(107)	(140)	(135)	(81)	(121)	(157)	(135)	(158)	(164)
Research & Development	(68)	(72)	(73)	(99)	(85)	(47)	(66)	(84)	(68)	(71)	(70)
Depreciation & Amortization	(7)	0	(16)	0	(25)	0	0	0	(33)	0	0
Other Operating Expenses	14	5	9	4	16	8	11	32	27	24	23
Operating Income	(8) N/A	(7) +20%	(8) -18%	(21) -161%	(21) -1%	(13) +38%	(6) +54%	14 N/A	31 +119%	43 +38%	46 +9%
Pre-Tax Income
Interest Income Expense	2	3	11	16	28	13	19	24	24	23	23
Non-Reccuring Items	0	0	(0)	0	(0)	0	0	0	(0)	1	1
Gain/Loss on Disposition of Assets	0	0	0	0	(0)	0	0	0	(0)	0	0
Total Other Income	(0)	(0)	0	(2)	(2)	(2)	(2)	(2)	(2)	(0)	(2)
Pre-Tax Income	(7) N/A	(4) +45%	3 N/A	(6) N/A	6 N/A	(2) N/A	11 N/A	36 +222%	52 +45%	66 +26%	68 +3%
Net Income
Tax Provision	0	0	0	0	0	0	0	0	(0)	(0)	(0)
Income from Continuing Operations	(7)	(4)	3	(6)	6	(2)	11	36	52	66	68
Net Income (Common)	(7) N/A	(4) +45%	3 N/A	(6) N/A	6 N/A	(2) N/A	11 N/A	36 +221%	52 +45%	66 +26%	68 +3%
EPS (Diluted)	-0.01 N/A	-0.01 N/A	0.01 N/A	-0.01 N/A	0.01 N/A	0 N/A	0.02 N/A	0.08 +300%	0.11 +38%	0.14 +27%	0.14 N/A

Shanghai MicroPort EP Medtech Co Ltd
SSE:688351